The positive mention of Syndax Pharmaceuticals by a high-profile investment officer on a widely viewed platform like CNBC can lead to increased investor interest and a short-term spike in share price. The immediate reaction of the market to such endorsements highlights the impact of media and analyst opinions on stock performance.